p97-mediated proteostasis is a checkpoint for late-stage thymocyte positive selection

  • Cell Mol Immunol. 2026 Oct;23(10):1343-1354. doi: 10.1038/s41423-026-01466-z.
Ruixian Yu  #  1  2 ,  Weihong Zhang  #  3 ,  Yi Han  3 ,  Wenjia Wang  2 ,  Yan Meng  4 ,  Pingping Nie  3 ,  Cuiwei Zhang  5 ,  Zaisheng Ye  6 ,  Bin Yan  7 ,  Zhaocai Zhou  8  9  10  11 ,  Shi Jiao  12
Affiliations
  • 1. Department of General Surgery, QingPu Branch of Zhongshan Hospital Affiliated with Fudan University, Shanghai, China.
  • 2. State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
  • 3. Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai, China.
  • 4. Department of Gastroenterology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • 5. Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • 6. Department of Gastric Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • 7. Department of General Surgery, QingPu Branch of Zhongshan Hospital Affiliated with Fudan University, Shanghai, China. [email protected].
  • 8. Department of General Surgery, QingPu Branch of Zhongshan Hospital Affiliated with Fudan University, Shanghai, China. [email protected].
  • 9. State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China. [email protected].
  • 10. Tianfu Jincheng Laboratory, Chengdu, China. [email protected].
  • 11. Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing, China. [email protected].
  • 12. State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China. [email protected].
  • # Contributed equally.
Abstract

AAA+ ATPase p97 is a central regulator of protein homeostasis, yet its role in late-stage thymocyte development remains undefined. Here, we demonstrate that T-cell-specific ablation of p97 in mice severely blocks the double-positive (DP) to single-positive (SP) transition, with a pronounced defect in CD8+ lineage commitment. Using both genetic deletion and acute pharmacological inhibition, we revealed a stage- and lineage-specific requirement for p97, with DP thymocytes being most sensitive to p97 loss. This failure in late-stage positive selection leads to intrathymic developmental arrest of immature DP cells and profound peripheral T-cell lymphopenia. Mechanistically, p97 deficiency results in the accumulation of ubiquitinated proteins, triggering the unfolded protein response and Apoptosis in thymocytes. Furthermore, we identified a critical requirement for p97 in sustaining IL-7 Receptor (IL-7R) expression and JAK signaling. Strikingly, pharmacological activation of JAK partially rescued SP thymocyte development in p97-deficient mice. Our findings establish p97-mediated protein homeostasis as a previously uncharacterized, cell-intrinsic checkpoint that is indispensable for late-stage positive selection by preventing proteostatic collapse and ensuring the fidelity of IL-7R signaling.

Keywords
IL-7R-JAK signaling; Positive selection; Protein homeostasis; Thymus; p97.
Products